Insight into Acinetobacter baumannii : pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities

Infection and Drug Resistance
Muhammad AsifShafiq Ur Rehman

Abstract

Acinetobacter baumannii, once considered a low-category pathogen, has emerged as an obstinate infectious agent. The scientific community is paying more attention to this pathogen due to its stubbornness to last resort antimicrobials, including carbapenems, colistin, and tigecycline, its high prevalence of infections in the hospital setting, and significantly increased rate of community-acquired infections by this organism over the past decade. It has given the fear of pre-antibiotic era to the world. To further enhance our understanding about this pathogen, in this review, we discuss its taxonomy, pathogenesis, current treatment options, global resistance rates, mechanisms of its resistance against various groups of antimicrobials, and future therapeutics.

Citations

May 19, 2019·Journal of Applied Microbiology·K SaipriyaV Sritharan
Dec 5, 2019·Water Science and Technology : a Journal of the International Association on Water Pollution Research·Tomislav IvankovicMarin Ganjto
Jun 17, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Bartłomiej GrygorcewiczBarbara Dołęgowska
Jan 5, 2020·Applied Microbiology and Biotechnology·Bora ShinWoojun Park
Nov 18, 2019·Current Infectious Disease Reports·David A ButlerEric Wenzler
Aug 28, 2020·Frontiers in Microbiology·Say Yong NgWilfried Moreira
Mar 11, 2020·Nature Reviews. Microbiology·Ursula TheuretzbacherGuy E Thwaites
Mar 6, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Alessandra OlivaRino Ragno
Nov 20, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Linda HadjadjBushra Jamil
Mar 7, 2021·International Journal of Environmental Research and Public Health·Andrea J GrisoldGernot E Zarfel
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Phui-Chyng YapHai Yen Lee
Apr 10, 2021·Antimicrobial Resistance and Infection Control·Marianna MeschiariCristina Mussini
Mar 8, 2020·Microbial Pathogenesis·Sepideh FereshtehFarzad Badmasti
May 4, 2021·Frontiers in Microbiology·Oliver McNeillyCindy Gunawan
Jun 10, 2021·Human Vaccines & Immunotherapeutics·NorAziyah Mat RahimSazaly AbuBakar

❮ Previous
Next ❯

Methods Mentioned

BETA
phosphotransferases

Software Mentioned

Vitek

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.